James E Turner, MD PHD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 6644 Summer Knoll Cir, Bartlett, TN 38134 Phone: 901-372-4545 Fax: 901-372-4310 |
Malika Tuli, MD Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6644 Summer Knoll Cir, Bartlett, TN 38134 Phone: 901-372-4545 Fax: 901-372-4310 |
News Archive
Testosterone therapy is not associated with a rise in estrogen levels among transgender men, according to a new study led by Boston Medical Center. In fact, the researchers observed an initial decline in estrogen levels, which later stabilized and remained within the normal range during the study's six-year period.
The nanoelectronics research centre imec and Peira, a Belgium-based manufacturer of pharmaceutical and chemical research instruments, jointly developed an innovative slice-tilting instrument for in-vitro research on brain tissue. The new tool enables long-term studying of brain cultures through electronic stimulation and read-out, essential in getting insight into the functioning of the brain.
Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have devised a novel method to expand the number of immune system "natural killer (NK)" cells from blood cells outside the body.
The number of children with medically complex illness, such as cancer, congenital heart disease or cerebral palsy, is increasing due to advances in pediatric care that have led to increased survival in previously high-mortality conditions. This population, despite representing only 10 percent of children, accounts for a substantial proportion of overall pediatric hospital costs.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, and Ascentage Pharma Group Corporation, Ltd. ("Ascentage Pharma") announced today that they have formed a strategic alliance to research, develop and commercialize best-in-class targeted cancer therapeutics focusing on programmed cell death, or apoptosis. The alliance will leverage Ascentage Pharma's expertise in structure-based small molecule design, lead optimization and preclinical development with 3SBio's proven drug development and commercialization capabilities in China.
› Verified 2 days ago